[ad_1] Text size Nasdaq-listed Antares Pharma is being bought by Halozyme Therapeutics in a deal valued at $960 million. Michael…
[ad_1] Text size Warren Buffett Paul Morigi/Getty Images for Fortune/Time Inc. Berkshire Hathaway has accumulated an 11.4% stake worth $4.2…